Literature DB >> 11204274

Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression.

R Stanzione1, A Picascia, P Chieffi, C Imbimbo, A Palmieri, V Mirone, S Staibano, R Franco, G De Rosa, J Schlessinger, D Tramontano.   

Abstract

Proline-rich kinase 2 (Pyk2), also known as CAKbeta (cell adhesion kinase beta), is a cytoplasmic tyrosine kinase that is structurally related to focal adhesion kinase. Pyk2 is expressed in different cell types including brain cells, fibroblasts, platelets, and other hemopoietic cells. Pyk2 is rapidly tyrosine phosphorylated in response to diverse extracellular signals acting via different post receptor pathways. We have investigated whether this protein kinase is functionally expressed in normal and neoplastic prostate tissues. In this study, we demonstrate that Pyk2 is expressed only in normal epithelial prostate tissue and in benign prostatic hyperplasia, whereas its expression progressively declines with an increasing grade of malignancy of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11204274     DOI: 10.1038/labinvest.3780211

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  18 in total

Review 1.  Nonreceptor tyrosine kinases in prostate cancer.

Authors:  Yu-Ming Chang; Hsing-Jien Kung; Christopher P Evans
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

Review 2.  Biochemical Changes in the Niche Following Tumor Cell Invasion.

Authors:  A M Decker; F C Cackowski; Y Jung; R S Taichman
Journal:  J Cell Biochem       Date:  2017-04-18       Impact factor: 4.429

Review 3.  Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights.

Authors:  Hyunho Yoon; Joshua P Dehart; James M Murphy; Ssang-Taek Steve Lim
Journal:  J Histochem Cytochem       Date:  2014-11-07       Impact factor: 2.479

4.  EPN: a novel epithelial cell line derived from human prostate tissue.

Authors:  Antonio A Sinisi; Paolo Chieffi; Daniela Pasquali; Annamaria Kisslinger; Stefania Staibano; Antonio Bellastella; Donatella Tramontano
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-03       Impact factor: 2.416

5.  Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells.

Authors:  Silke Kaulfuss; Michal Grzmil; Bernhard Hemmerlein; Paul Thelen; Stefan Schweyer; Jürgen Neesen; Lukas Bubendorf; Andrew G Glass; Hubertus Jarry; Bernd Auber; Peter Burfeind
Journal:  Mol Endocrinol       Date:  2008-05-01

Review 6.  CaMKK2: a novel target for shaping the androgen-regulated tumor ecosystem.

Authors:  Luigi Racioppi
Journal:  Trends Mol Med       Date:  2013-01-14       Impact factor: 11.951

7.  Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.

Authors:  Emy Behmoaram; Krikor Bijian; Su Jie; Yingjie Xu; Andrew Darnel; Tarek A Bismar; Moulay A Alaoui-Jamali
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

8.  HCMV pUS28 initiates pro-migratory signaling via activation of Pyk2 kinase.

Authors:  Jennifer Vomaske; Susan Varnum; Ryan Melnychuk; Patricia Smith; Ljiljana Pasa-Tolic; Janani I Shutthanandan; Daniel N Streblow
Journal:  Herpesviridae       Date:  2010-12-07

9.  The role of SRC family kinases in prostate cancer.

Authors:  Oleg Tatarov; Joanne Edwards
Journal:  Transl Oncogenomics       Date:  2007-10-14

10.  Proline-rich tyrosine kinase 2 and its phosphorylated form pY881 are novel prognostic markers for non-small-cell lung cancer progression and patients' overall survival.

Authors:  B-H Kuang; M-Q Zhang; L-H Xu; L-J Hu; H-B Wang; W-F Zhao; Y Du; X Zhang
Journal:  Br J Cancer       Date:  2013-08-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.